BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35980227)

  • 1. Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation.
    Demory A; Péron JM; Calderaro J; Selves J; Mokrane FZ; Amaddeo G; Paradis V; Ziol M; Sutter O; Blaise L; Ganne-Carrié N; Vilgrain V; Cauchy F; Zucman-Rossi J; Ronot M; Nault JC
    Hepatology; 2023 Feb; 77(2):430-442. PubMed ID: 35980227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of liver adenomatosis: A long-term observational study.
    Barbier L; Nault JC; Dujardin F; Scotto B; Besson M; de Muret A; Bourlier P; Zucman-Rossi J; Salamé E; Bacq Y
    J Hepatol; 2019 Dec; 71(6):1184-1192. PubMed ID: 31419515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study.
    Qureshy Z; Lokken RP; Kakar S; Grab J; Mehta N; Sarkar M
    Contraception; 2023 Mar; 119():109915. PubMed ID: 36476331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing trends in malignant transformation of hepatocellular adenoma.
    Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
    Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular adenomas: review of pathological and molecular features.
    Beaufrère A; Paradis V
    Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Vernuccio F; Ronot M; Dioguardi Burgio M; Cauchy F; Choudhury KR; Dokmak S; Soubrane O; Valla D; Zucman-Rossi J; Paradis V; Vilgrain V
    Radiology; 2020 May; 295(2):361-372. PubMed ID: 32181728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
    Klompenhouwer AJ; Alblas M; van Rosmalen BV; Haring MPD; Venema E; Doukas M; Thomeer MGJ; Takkenberg RB; Verheij J; de Meijer VE; van Gulik TM; Lingsma HF; de Man RA; Ijzermans JNM
    Am J Gastroenterol; 2019 Aug; 114(8):1292-1298. PubMed ID: 30920416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study.
    Haring MPD; Gouw ASH; de Haas RJ; Cuperus FJC; de Jong KP; de Meijer VE
    Liver Int; 2019 May; 39(5):905-913. PubMed ID: 30773766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study on timing of resection of hepatocellular adenoma.
    Klompenhouwer AJ; Bröker MEE; Thomeer MGJ; Gaspersz MP; de Man RA; IJzermans JNM
    Br J Surg; 2017 Nov; 104(12):1695-1703. PubMed ID: 28857134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features.
    Poté N; Caruso S; Caderaro J; Cauchy F; Lagadec F; Couchy G; Raffenne J; Augustin J; Vernuccio F; Vilgrain V; Hercent A; Theou-Anton N; Zucman-Rossi J; Paradis V
    Mod Pathol; 2023 Sep; 36(9):100211. PubMed ID: 37169258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New MRI features improve subtype classification of hepatocellular adenoma.
    Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
    Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
    Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
    Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
    Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
    Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of hepatic adenomas.
    Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
    Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
    González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
    Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for bleeding hepatocellular adenoma in a United States cohort.
    McDermott C; Ertreo M; Jha R; Ko J; Fernandez S; Desale S; Fishbein T; Satoskar R; Winslow E; Smith C; Hsu CC
    Liver Int; 2022 Jan; 42(1):224-232. PubMed ID: 34687281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.